• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection
  • News
  • Opinion
  • About
  • Glossary

PV Analytics

Deep Learning, Machine Learning, and Artificial Intelligence – What are the Differences?

March 18, 2018 by Jose Rossello Leave a Comment

In this video, Bernardo F. Nunes explains how these 3 concepts (artificial intelligence, machine learning, and deep learning) do not represent the same thing:

Bernardo is breaking down the 3 concepts for us, in a very easy and understandable way.

Artificial intelligence exists when a machine has cognitive capabilities, such as problem solving and learning. It’s normally associated to a human benchmark, as, for example reasoning, speech, and vision.

In the video, he differentiates 3 levels of A.I.:

  1. Narrow A.I., when a machine is better than us in a specific task (we are here now)
  2. General A.I., when a machine is like us in any intellectual task
  3. Strong A.I, when a machine is better than us in many tasks

One of the favorites early developments in A.I. is the perceptron (1957). It was a single layer of artificial neural networks designed for image recognition. They are called neural networks because the first practitioners on A.I. thought that these interconnected nodes looked like the human neural system, which has neural networks. These are the natural neural networks. The perceptron is a rudimentary version of an artificial neural network.

Machine learning, appeared on the 1980s, when a body of researchers worked on what is called supervised learning. Algorithms are trained with datasets based on past examples, in a model in which the trained algorithm is applied to a new dataset for classification purposes. Widely used for business purposes.

Deep learning makes use of deep neural networks. Shallow neural nets have only one hidden layer between the input and the output. However, deep neural nets have 2 or more hidden layers between the input and the output. It’s the responsible for the advancement in image recognition. If you can represent an image numerically, then you can process it with deep learning.

Bernardo’s conclusion is that deep learning, machine learning, and artificial intelligence are not 3 different things. They simply are subsamples of each other: deep learning belongs to machine learning, and machine learning belongs to artificial intelligence.

Jose Rossello
Jose Rossello

Filed Under: PV Analytics Tagged With: AI, artificial intelligence, deep learning, machine learning

Primary Sidebar

Subscribe in a reader

Featured News / Posts

Analysis Of Textual Data May Complement Traditional Pharmacovigilance

According to a well-written systematic review on the application of natural … [Read More...] about Analysis Of Textual Data May Complement Traditional Pharmacovigilance

Machine Learning and Pharmacovigilance

Machine learning (ML) is becoming increasingly available to everyone, including … [Read More...] about Machine Learning and Pharmacovigilance

clinical trial follow-up

Post-Randomization vs On Treatment Made All the Difference

The Food and Drug Administration (FDA) recently requested withdraw of Belviq® … [Read More...] about Post-Randomization vs On Treatment Made All the Difference

Pharmacovigilance Audits/Inspections and PV Analytics!

Disclaimer: This article is written by a Safety Physician to provide … [Read More...] about Pharmacovigilance Audits/Inspections and PV Analytics!

Artificial Intelligence in pharmacovigilance? What a challenge!

Abstract Pharmaceutical industry, and more particularly pharmacovigilance, … [Read More...] about Artificial Intelligence in pharmacovigilance? What a challenge!

Some Sample Triples

Knowledge Graphs, Semantic Web and Drug Safety

Second part of: Mining PubMed for Drug Induced Acute Kidney Injury When I … [Read More...] about Knowledge Graphs, Semantic Web and Drug Safety

Review of Safety in FDA Medical Reviews

Analysis of the latest review of safety sections for new drug applications (NDAs … [Read More...] about Review of Safety in FDA Medical Reviews

Mining PubMed for Drug Induced Acute Kidney Injury

Enhancing signal detection capabilities beyond regular literature … [Read More...] about Mining PubMed for Drug Induced Acute Kidney Injury

Top 7 Predictive Model Applications in Drug Safety and Pharmacovigilance

As drug safety and pharmacovigilance organizations develop more sophisticated … [Read More...] about Top 7 Predictive Model Applications in Drug Safety and Pharmacovigilance

The Pharmacovigilance of the Future: Prospective, Proactive, and Predictive

Peter J Pitts, President of the Center for Medicine in the Public Interest, and … [Read More...] about The Pharmacovigilance of the Future: Prospective, Proactive, and Predictive

  • Disproportional Recording vs Disproportional Reporting
  • Deep Learning, Machine Learning, and Artificial Intelligence – What are the Differences?
  • How Organizations Use Social Media For Pharmacovigilance

RSS From Nature journal

  • Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
  • Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database
  • Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
  • A genetic test to predict adverse drug reactions
  • The evolving role of investigative toxicology in the pharmaceutical industry

Copyright © 2023 · News Pro on Genesis Framework · WordPress · Log in